TABLE 1.
Characteristic | No. of cases | URB1 expression | P value a | |
---|---|---|---|---|
Low | High | |||
Age (y) | ||||
≤60 | 22 | 9 | 13 | .697 |
>60 | 79 | 36 | 43 | |
Gender | ||||
Male | 50 | 19 | 31 | .189 |
Female | 51 | 26 | 25 | |
Pathologic subtype | ||||
Adenocarcinoma | 63 | 30 | 33 | .429 |
Mucinous adenocarcinoma | 38 | 15 | 23 | |
Pathological grading | ||||
pG1 | 23 | 16 | 7 | .023* |
pG2 | 62 | 23 | 39 | |
pG3 | 16 | 6 | 10 | |
Primary tumor | ||||
T1, T2 | 6 | 5 | 1 | .012* |
T3 | 75 | 36 | 39 | |
T4 | 20 | 4 | 16 | |
Lymph node status | ||||
N0 | 61 | 29 | 32 | .757 |
N1 | 30 | 12 | 18 | |
N2 | 10 | 4 | 6 | |
TNM stage | ||||
I | 6 | 5 | 1 | .005** |
II | 54 | 29 | 25 | |
III‐IV | 41 | 11 | 30 |
χ2 test.
P < .05.
P < .01.